Yahoo! Finance: Top Stories

Travere Therapeutics price target raised to $30 from $24 at TD Cowen

Feb 24, 2025 - 02:11
 0
Travere Therapeutics price target raised to $30 from $24 at TD Cowen
Read More

Tags:

Previous Article

Kodiak Sciences: Anti-VEGF Could Win Nicely On Retinal Disorders

Next Article

BridgeBio price target raised to $52 from $49 at Scotiabank

Related Posts

Gold Rises to Near-Record on Persistent Safe-Haven Demand

Gold Rises to Near-Record on Persistent Safe-Haven Demand

Feb 15, 2025  0

An Investing Riddle: Stocks Are in Turmoil but Stock Markets Aren’t

An Investing Riddle: Stocks Are in Turmoil but Stock Ma...

Feb 18, 2025  0

Upstart, Stock Of The Day, Flirts With Buy Point After 232% Rally

Upstart, Stock Of The Day, Flirts With Buy Point After ...

Feb 20, 2025  0